The veterinary vaccines market sales is predicted to have expanded from US$ 11.3 billion in 2023 to over US$ 20.82 billion by 2033. This is expected to generate a compound annual growth rate (CAGR) of 6.2% from 2023 to 2033 and further increase the market share of veterinary vaccinations.
The increasing awareness among pet owners, livestock farmers, and veterinarians about the significance of animal health has been a key driver for the Veterinary Vaccines Market. Governments and regulatory bodies worldwide have also recognized the importance of disease prevention in animals to ensure public health and food safety. This heightened focus on animal health has led to a surge in research and development activities, aiming to create innovative and more effective veterinary vaccines. Moreover, the shift from reactive to proactive veterinary care has further accelerated the adoption of vaccination programs, driving market growth.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-409
In recent years, significant advancements in biotechnology and vaccine development have revolutionized the Veterinary Vaccines Market. Novel vaccine platforms, such as recombinant vaccines and vectored vaccines, offer improved efficacy and safety profiles, providing veterinarians and animal owners with a broader range of preventive options. Additionally, advancements in adjuvant technologies and formulation techniques have enhanced vaccine stability and immune response, contributing to the success of vaccination campaigns and disease control efforts. The continuous progress in vaccine technology promises to bring forth even more innovative solutions to address emerging infectious challenges in the veterinary sector.
With the increasing occurrence of zoonotic diseases (diseases that can be transmitted from animals to humans) in recent times, the role of veterinary vaccines in preventing zoonotic infections has gained paramount importance. Diseases like rabies, avian influenza, and brucellosis pose significant threats to both animal and human populations. By immunizing animals against zoonotic agents, veterinary vaccines act as a crucial barrier in breaking the transmission cycle and safeguarding public health. Governments and international organizations have been actively promoting zoonotic disease prevention through comprehensive vaccination programs, further fueling the demand for veterinary vaccines.
The Veterinary Vaccines Market has witnessed notable growth in developing regions, attributed to several factors. Rising livestock production, increasing pet ownership, and growing awareness of animal health in these regions have contributed to market expansion. Additionally, collaborations between international vaccine manufacturers and local players have facilitated the transfer of technology and expertise, further boosting vaccine accessibility and affordability. As these regions continue to experience economic growth and urbanization, the demand for quality veterinary vaccines is projected to surge, presenting new opportunities for market players.
The net worth of the veterinary vaccine market share is expected to rise from US$ 11.3 billion in 2023 to more than US$ 20.82 billion by 2033. This is expected to increase veterinary vaccine market share and register a CAGR of 6.2% between 2023 and 2033.
The global veterinary vaccines market is expected to grow at a healthy 7.2% CAGR between 2022 and 2026. The global market was expected to grow at a 6.5% YoY rate in 2021, with the global veterinary vaccines market valued at around US$ 10 billion. By 2026, the market is expected to be valued at more than US$ 14.1 billion.
The growth of the global veterinary vaccines market is expected to surge amid the increasing prevalence of animal diseases all over the world. Sales of veterinary vaccines accounted for around 91.3% share of the global veterinary biologics market in 2021. Based on product, the attenuated live vaccines segment leads the veterinary vaccines market with nearly ¼ market share.
As the threat of another pandemic bestows over the world, improving animal health is one of the major priorities for people and governments all over the world. On an annual basis, billions of dollars are being spent on pharmaceuticals and vaccines to protect animals from a wide range of diseases as well as to improve their immunity. This is expected to generate growth prospects for veterinary vaccine suppliers and manufacturers during the forecast period. Surging efforts to develop vaccines for zoonotic diseases which are also commonly found in humans as well is set to improve the growth of the overall veterinary vaccines market.
Veterinary vaccines have rapidly become ideal preventive healthcare solutions in order to protect animals from developing and contracting lethal diseases as well as for improving their immunity systems. These vaccines allow pet owners and farmers to significantly reduce the spread of infectious diseases, improve their pet’s health and minimize healthcare costs. The variation between the BPS values observed within the global veterinary vaccines market in H1, 2022 – outlook over the H1, 2022 projected period reflects a decline of 20 BPS units. Furthermore, a decline in BPS growth in H1-2022 over H1-2021 by 13 Basis Point Share (BPS) is demonstrated by the market.
Key Takeaways:
- The global veterinary vaccines market is gaining traction over the projection period due to the rising prevalence of zoonotic diseases, surging demand for animal products, and growing trend of pet adoption across the world. Among some of the key driving factors of the global veterinary vaccines market is the exponential growth of the animal healthcare products market.
- The rapid expansion of the veterinary respiratory disease treatment market along with the veterinary pain management drugs market attributed to the increasing spending by pet owners on improving the health of their pets will create sales prospects for veterinary vaccines throughout the forecast period.
- Massive popularity can be seen within the veterinary vaccines market for their potential to protect animal health along with public health as they effectively mimic naturally acquired immunity. Among the developing nations, veterinary vaccine sales are estimated to be high owing to the increasing pet ownership. These vaccines play a crucial role in assuring longevity and good health in animals.
- The introduction of technologically advanced vaccinations, increasing livestock population, rising government investments and initiatives to tackle the burden of animal diseases, and expanding pet care market across developing regions are anticipated to create growth avenues within the global veterinary vaccines market during the forthcoming years.
- The rapid surge in the animal healthcare market combined with the companion animal vaccines market is anticipated to generate lucrative prospects for the manufacturers of veterinary vaccines during the forecast period between 2022 and 2026.
Competitive Landscape:
Key players profiled in the global veterinary vaccines market are focusing on continuous investments in research and development activities for the introduction of effective vaccines. Besides this, leading veterinary vaccine manufacturers are adopting various market strategies such as joint ventures, collaborations, partnership agreements, sales agreements, and capacity expansion to expand their global footprint.
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-409
More Insights into the Veterinary Vaccines Market
The U.S. is anticipated to be a dominant market for veterinary vaccines attributing to the surging frequency of drug approvals, advances in veterinary science, rise in pet adoption rate, and the emergence of new veterinary vaccine market trends.
China is yet another country emerging as an opportunistic market for veterinary vaccines, combined by collaborative initiatives of governments and private firms in order to promote better animal healthcare with advanced veterinary medical devices.
Key Companies:
- Boehringer Ingelheim GmbH,
- Zoetis Inc.
- Elanco Animal Health,
- Merck & Co., Inc.
- Bayer AG
- Virbac Group
- Ceva Santé Animale
- Phibro Animal Health Corporation
- Others
Veterinary Vaccines Market Segmentation by Category
By Product:
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
By Disease:
- Anaplasmosis
- Canine Parvovirus
- Foot & Mouth Disease
- New Castle Disease
- Distemper Disease
- Influenza
- Porcine Reproductive & Respiratory Syndrome (PRRS)
- Others
By Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
By Species:
- Companion Animals
- Canine
- Avian
- Feline
- Livestock Animals
- Aquatic
- Bovine
- Porcine
- Ovine/Caprine
- Poultry
- Equine
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube